ONIVYDE irinotecan (as sucrosofate) 43 mg/10 mL  nanoliposomal concentrated injection for infusion Australia - English - Department of Health (Therapeutic Goods Administration)

onivyde irinotecan (as sucrosofate) 43 mg/10 ml nanoliposomal concentrated injection for infusion

servier laboratories (aust) pty ltd - irinotecan hydrochloride trihydrate, quantity: 5 mg/ml - injection, concentrated - excipient ingredients: distearoylphosphatidylcholine; cholesterol; sodium methoxy peg-40-carbonyl-distearoylphosphatidylethanolamine; hepes; sodium chloride; water for injections; sucrosofate - onivyde is indicated:,? in combination with oxaliplatin and 5 fluorouracil (5 fu) and leucovorin (lv) for the first-line treatment of metastatic pancreatic adenocarcinoma.,? in combination with 5-fu and lv for the treatment of metastatic pancreatic adenocarcinoma after disease progression following gemcitabine-based therapy.

GLYADE MR gliclazide 30mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

glyade mr gliclazide 30mg tablet blister pack

servier laboratories (aust) pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; maltodextrin; magnesium stearate; hypromellose; calcium hydrogen phosphate dihydrate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.

INDOSYL MONO Australia - English - Department of Health (Therapeutic Goods Administration)

indosyl mono

servier laboratories (australia) pty ltd - perindopril erbumine -

Perindo Australia - English - Department of Health (Therapeutic Goods Administration)

perindo

servier laboratories (australia) pty ltd - perindopril erbumine -

IDAPREX COMBI 4/1.25 Australia - English - Department of Health (Therapeutic Goods Administration)

idaprex combi 4/1.25

servier laboratories (australia) pty ltd - perindopril erbumine; indapamide hemihydrate -